DCF — ST. JOHN MEDICAL CENTER
Enterprise Value: $-266.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-266.9M
Enterprise Value
$-90.4M
PV of Cash Flows
$-176.5M
PV of Terminal Value
$-284.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $345.0M | $-13.4M | -4.0% | $-28.0M | $-25.4M |
| Year 2 | $355.4M | $-10.2M | -3.0% | $-25.3M | $-20.9M |
| Year 3 | $366.0M | $-6.9M | -2.0% | $-22.3M | $-16.8M |
| Year 4 | $377.0M | $-5.2M | -1.0% | $-21.1M | $-14.4M |
| Year 5 | $388.3M | $-4.4M | -1.0% | $-20.8M | $-12.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-266.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$335.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04372679452422815
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5